CORTROSYN™ (cosyntropin) for Injection exhibits slight immunolog-ic activity, does not contain animal protein and is therefore less risky to use than natural ACTH. Patients known to be sensitized to natural ACTH with markedly positive skin tests will, with few exceptions, re-act negatively when tested intradermally with CORTROSYN™ (cosyntropin) . Most patients with a history of a previous hypersensitivity reaction to natural ACTH or a pre-existing allergic disease will tolerate CORTROSYN™ (cosyntropin) . Despite this however, CORTROSYN™ (cosyntropin) is not completely devoid of immunologic activity and hypersensitivity reactions including rare anaphylaxis are possible. Therefore, the physician should be pre-pared, prior to injection, to treat any possible acute hypersensitivity reaction.
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long term studies in animals have not been performed to evaluate carcinogenic or mutagenic potential or impairment of fertility. A study in rats noted inhibition of reproductive function like natural ACTH.
Pregnancy Category C. Animal reproduction studies have not been conducted with CORTROSYN™ (cosyntropin) for Injection. It is also not known whether CORTROSYN™ (cosyntropin) can cause fetal harm when ad-ministered to a pregnant woman or can affect reproduction capacity. CORTROSYN™ (cosyntropin) should be given to a pregnant woman only if clearly needed.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when CORTROSYN™ (cosyntropin) for Injection is administered to a nursing woman.
(See DOSAGE AND ADMINISTRATION section.)
Last reviewed on RxList: 9/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Cortrosyn Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.